Biotech

All Articles

Orion to make use of Aitia's 'digital twins' to discover new cancer drugs

.Finnish biotech Orion has spied potential in Aitia's "digital twin" technology to build new cancer ...

Windtree's surprise med rears blood pressure in most current phase 2 win

.While Windtree Therapies has struggled to grow the monetary roots needed to make it through, a peri...

2 cancer biotechs merge, generating international impact

.OncoC4 is actually taking AcroImmune-- as well as its own in-house professional manufacturing funct...

Amgen files 1st phase 3 win for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the first period 3 data on its own $400 million dermatitis drug,...

Biogen, UCB file stage 3 lupus win after neglecting earlier trial

.Biogen and UCB's gamble on developing right into stage 3 astride a failed research study aims to ha...

Aptadir really hopes brand-new RNA inhibitors may reverse tricky cancers

.Italian biotech Aptadir Therapeutics has actually introduced along with the commitment that its own...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending out stockpile

.Wave Life Sciences has actually met its objective in a Duchenne muscular dystrophy (DMD) study, pos...

Sanofi picks brand-new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, using u...

Achilles trickles tissue treatment program, bandages for cutbacks after skipping 'office stability' targets

.Achilles Therapeutics has actually wrecked its own tactic. The English biotech is stopping work on ...

Aligos heralds stage 2 MASH win, lowering liver fat approximately 46%

.Aligos Rehabs is actually trumpeting a midstage win in metabolic-dysfunction associated steatohepat...